RESPIRATORY SYNCYTIAL VIRUS (RSV) - ANVISA Registration 10259610155

Access comprehensive regulatory information for RESPIRATORY SYNCYTIAL VIRUS (RSV) in Brazil's medical device market through Pure Global AI's free database. This Risk Class II medical device is registered under ANVISA number 10259610155 and manufactured by QUIDEL CORPORATION. The registration is held by MEDIVAX INDÚSTRIA E COMÉRCIO LTDA with validity until currently active (VIGENTE).

This page provides complete technical specifications for this device, regulatory compliance details, 5 similar products found using AI-powered semantic search, 5 companies making the same product including HANGZHOU ALLTEST BIOTECH CO. LTD, ABBOTT DIAGNOSTICS SCARBOROUGH, INC, and 5 recent registrations in the same technical category. Pure Global AI offers free access to over 100,000+ Brazilian medical device registrations, helping global MedTech companies navigate ANVISA regulations, identify competitors, and discover partnership opportunities efficiently.